Therapeutic assessments revealed significant improvements in recovery, accelerated hematoma clearance, and reduced inflammation, highlighting the potential of IL-10-loaded nanoparticles for the targeted treatment of intracerebral hemorrhage. This evidence concerns the gene IL10 and intracerebral hemorrhage.